Association between left atrial size and atrial fibrillation recurrence after single circumferential pulmonary vein isolation: A systematic review and meta-analysis of observational studies

Europace

Volumn 14, Issue 5, 2012, Pages 638-645

  Zhuang, Jianhui ^a   Wang, Yi ^b   Tang, Kai ^a   Li, Xiankai ^a   Peng, Wenhui ^a   Liang, Chun ^b   Xu, Yawei ^a  

^a TONGJI UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Atrial fibrillation; Catheter ablation; Left atrial size; Meta analysis; Recurrence

Indexed keywords

ARTICLE; CIRCUMFERENTIAL PULMONARY VEIN ISOLATION; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HUMAN; PRIORITY JOURNAL; PULMONARY VEIN ISOLATION; RECURRENT DISEASE; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; SYSTOLE; TRANSTHORACIC ECHOCARDIOGRAPHY;

ATRIAL FIBRILLATION; CARDIOMEGALY; CATHETER ABLATION; HEART ATRIA; HUMANS; PULMONARY VEINS; RECURRENCE; RISK FACTORS;

EID: 84860476111     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur364     Document Type: Article

References (42)

1. Jais P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: The A4 study. Circulation 2008;118:2498-505.
2. Oral H, Pappone C, Chugh A, Good E, Bogun F, Pelosi F Jr et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med 2006;354: 934-41.
3. Wann LS, Curtis AB, Ellenbogen KA, Estes NA 3rd, Ezekowitz MD, Jackman WM et al. 2011 ACCF/AHA/HRS Focused update on the management of patients with atrial fibrillation (update on Dabigatran). A report of the American College of Cardiology Foundation Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2011;57:1330-7.
4. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 2010;3:32-8.
5. Olshansky B, Heller EN, Mitchell LB, Chandler M, Slater W, Green M et al. Are transthoracic echocardiographic parameters associated with atrial fibrillation recurrence or stroke? Results from the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study. J Am Coll Cardiol 2005;45:2026-33. (Pubitemid 40814127)
6. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12. (Pubitemid 30214957)
7. Verma A, Wazni OM, Marrouche NF, Martin DO, Kilicaslan F, Minor S et al. Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: An independent predictor of procedural failure. J Am Coll Cardiol 2005; 45:285-92. (Pubitemid 40094739)
8. Kirchhof P, Auricchio A, Bax J, Crijns H, Camm J, Diener HC et al. Outcome parameters for trials in atrial fibrillation: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association. Europace 2007;9:1006-23. (Pubitemid 351773289)
9. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60. (Pubitemid 37088507)
10. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58. (Pubitemid 34746062)
11. Verma A, Mantovan R, Macle L, De Martino G, Chen J, Morillo CA et al. Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): A randomized, multicentre, international trial. Eur Heart J 2010;31:1344-56.
12. Gaita F, Caponi D, Scaglione M, Montefusco A, Corleto A, Di Monte F et al. Long- term clinical results of 2 different ablation strategies in patients with paroxysmal and persistent atrial fibrillation. Circ Arrhythm Electrophysiol 2008;1:269-75.
13. Verma A, Marrouche NF, Yamada H, Grimm RA, Cummings J, Burkhardt JD et al. Usefulness of intracardiac Doppler assessment of left atrial function immediately post-pulmonary vein antrum isolation to predict short-term recurrence of atrial fibrillation. Am J Cardiol 2004;94:951-4. (Pubitemid 39349567)
14. Delgado V, Vidal B, Sitges M, Tamborero D, Mont L, Berruezo A et al. Fate of left atrial function as determined by real-time three-dimensional echocardiography study after radiofrequency catheter ablation for the treatment of atrial fibrillation. Am J Cardiol 2008;101:1285-90.
15. Husser D, Adams V, Piorkowski C, Hindricks G, Bollmann A. Chromosome 4q25 variants and atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol 2010;55:747-53.
16. Nakazawa Y, Ashihara T, Tsutamoto T, Ito M, Horie M. Endothelin-1 as a predictor of atrial fibrillation recurrence after pulmonary vein isolation. Heart Rhythm 2009;6:725-30.
17. Efremidis M, Sideris A, Xydonas S, Letsas KP, Alexanian IP, Manolatos D et al. Ablation of atrial fibrillation in patients with heart failure: Reversal of atrial and ventricular remodelling. Hellenic J Cardiol 2008;49:19-25. (Pubitemid 351499657)
18. Pappone C, Santinelli V, Manguso F, Vicedomini G, Gugliotta F, Augello G et al. Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation 2004;109:327-34. (Pubitemid 38133899)
19. Kuppahally SS, Akoum N, Badger TJ, Burgon NS, Haslam T, Kholmovski E et al. Echocardiographic left atrial reverse remodeling after catheter ablation of atrial fibrillation is predicted by preablation delayed enhancement of left atrium by magnetic resonance imaging. Am Heart J 2010;160:877-84.
20. Yamada T, Yoshida N, Murakami Y, Okada T, Yoshida Y, Muto M et al. The difference in autonomic denervation and its effect on atrial fibrillation recurrence between the standard segmental and circumferential pulmonary vein isolation techniques. Europace 2009;11:1612-9.
21. Liu Z, Ling Z, Su L, Wu J, Lan X, Chen Y et al. The effect of different treatment strategies on left atrial size in patients with lone paroxysmal atrial fibrillation-a prospective cohort study. J Interv Card Electrophysiol 2008;23:167-73.
22. Tang RB, Dong JZ, Liu XP, Kang JP, Ding SF, Wang L et al. Obstructive sleep apnoea risk profile and the risk of recurrence of atrial fibrillation after catheter ablation. Europace 2009;11:100-5.
23. Bertaglia E, Zerbo F, Zoppo F, Trivellato M, Favaro A, Pascotto P. Pulmonary vein isolation predicts freedom from arrhythmia after circumferential antral ablation for paroxysmal atrial fibrillation. J Cardiovasc Med (Hagerstown) 2007;8:896-903. (Pubitemid 47517732)
24. Letsas KP,Weber R, Burkle G, Mihas CC, Minners J, Kalusche D et al. Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: The potential role of inflammation. Europace 2009;11:158-63.
25. Al Chekakie MO, Akar JG, Wang F, Al Muradi H, Wu J, Santucci P et al. The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation. J Cardiovasc Electrophysiol 2007;18: 942-6. (Pubitemid 47339045)
26. Tang RB, Dong JZ, Liu XP, Fang DP, Long de Y, Liu XH et al. Safety and efficacy of catheter ablation of atrial fibrillation in patients with diabetes mellitus - single center experience. J Interv Card Electrophysiol 2006;17:41-6. (Pubitemid 46295282)
27. De Potter T, Berruezo A, Mont L, Matiello M, Tamborero D, Santibanez C et al. Left ventricular systolic dysfunction by itself does not influence outcome of atrial fibrillation ablation. Europace 2010;12:24-9.
28. Kurotobi T, Iwakura K, Inoue K, Kimura R, Okamura A, Koyama Y et al. A pre-existent elevated C-reactive protein is associated with the recurrence of atrial tachyarrhythmias after catheter ablation in patients with atrial fibrillation. Europace 2010;12:1213-8.
29. Bertaglia E, Stabile G, Senatore G, Turco P, Donnici G, De Simone A et al. Longterm outcome of right and left atrial radiofrequency ablation in patients with persistent atrial fibrillation. Pacing Clin Electrophysiol 2006;29:153-8.
30. Chao TF, Sung SH,Wang KL, Lin YJ, Chang SL, Lo LWet al. Associations between the atrial electromechanical interval, atrial remodelling and outcome of catheter ablation in paroxysmal atrial fibrillation. Heart 2010;97:225-30.
31. Patel D, Mohanty P, Di Biase L,Wang Y, Shaheen MH, Sanchez JE et al. The impact of statins and renin-angiotensin-aldosterone system blockers on pulmonary vein antrum isolation outcomes in post-menopausal females. Europace 2010;12: 322-30.
32. Miyazaki S, Kuwahara T, Kobori A, Takahashi Y, Takei A, Sato A et al. Preprocedural predictors of atrial fibrillation recurrence following pulmonary vein antrum isolation in patients with paroxysmal atrial fibrillation: Long-term follow-up results. J Cardiovasc Electrophysiol 2011;22:621-5.
33. Shin SY, Na JO, Lim HE, Choi CU, Choi JI, Kim SH et al. Improved endothelial function in patients with atrial fibrillation through maintenance of sinus rhythm by successful catheter ablation. J Cardiovasc Electrophysiol 2011;22: 376-82.
34. Li XP, Dong JZ, Liu XP, Long de Y, Yu RH, Tian Y et al. Predictive value of early recurrence and delayed cure after catheter ablation for patients with chronic atrial fibrillation. Circ J 2008;72:1125-9. (Pubitemid 351957079)
35. Tops LF, Delgado V, Bertini M, Marsan NA, Den Uijl DW, Trines SA et al. Left atrial strain predicts reverse remodeling after catheter ablation for atrial fibrillation. J Am Coll Cardiol 2011;57:324-31.
36. Burstein B, Nattel S. Atrial fibrosis: Mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 2008;51:802-9. (Pubitemid 351260071)
37. Yue L, Xie J, Nattel S. Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation. Cardiovasc Res 2011;89: 744-53.
38. Oakes RS, Badger TJ, Kholmovski EG, Akoum N, Burgon NS, Fish EN et al. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation 2009;119:1758-67.
39. Dobrev D, Nattel S. New antiarrhythmic drugs for treatment of atrial fibrillation. Lancet 2010;375:1212-23.
40. Balk EM, Garlitski AC, Alsheikh-Ali AA, Terasawa T, Chung M, Ip S. Predictors of atrial fibrillation recurrence after radiofrequency catheter ablation: A systematic review. J Cardiovasc Electrophysiol 2010;21:1208-16.
41. den Uijl DW, Delgado V, Bertini M, Tops LF, Trines SA, van de Veire NR et al. Impact of left atrial fibrosis and left atrial size on the outcome of catheter ablation for atrial fibrillation. Heart 2011;97:1847-51.
42. Tops LF, Bax JJ, Zeppenfeld K, Jongbloed MR, van derWall EE, Schalij MJ. Effect of radiofrequency catheter ablation for atrial fibrillation on left atrial cavity size. Am J Cardiol 2006;97:1220-2.